Benefits and risks of increasing restrictions on access to costly drugs in Medicaid
By: by Stephen B. Soumerai.
Contributors: Public Policy Institute (AARP (Organization))
Publisher: AARP Public Policy Institute
Published: 2004
Place of publication: Washington, DC
Language: eng
Number of pages: 16
Subjects: Medicaid; Fees, Pharmaceutical; Health Care Rationing; Risk Assessment
Notes: "March 2004."

Includes bibliographical references.